Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Novavax (Sweden)
h-index: 16
Total citations: 1,799
Total papers: 37
Homepage:
https://novavax.com/
Recent papers from Novavax (Sweden)
Abstract C066: Matrix-M adjuvant – A promising adjuvant for preventative and therapeutic cancer vaccines development
Cancer Immunology Research · 2026
Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization
npj Vaccines · 2025
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials
The Lancet Microbe · 2025
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies
Cell Reports Medicine · 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
The Lancet Infectious Diseases · 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Nature Communications · 2024
A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial
BMC Medicine · 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
2024
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults
Journal of Clinical Investigation · 2024
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial
npj Vaccines · 2024
Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies
2024
The Surface of Ionic Liquids in Water: From an Ionic Tug of War to a Quasi‐Ordered Two‐Dimensional Layer
ChemPhysChem · 2023
Biodistribution of the saponin-based adjuvant Matrix-M™ following intramuscular injection in mice
Frontiers in Drug Delivery · 2023
Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans
Scientific Reports · 2023
PvDBPII-Matrix M elicits polyfunctional antibodies that limit parasite growth in a challenge trial
2023
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
Science Translational Medicine · 2023
The Matrix-M™ adjuvant: A critical component of vaccines for the 21 st century
Human Vaccines & Immunotherapeutics · 2023
Overexpression of the plastidal pseudo-protease AtFtsHi3 confers drought tolerance without penalizing growth
2022
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial
The Lancet Infectious Diseases · 2022
HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection
Nature Communications · 2022